HEADER UNKNOWN FUNCTION 27-FEB-21 7NPL TITLE ALPHA-1 ANTITRYPSIN (C232S) COMPLEXED WITH CMPD 11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1-ANTITRYPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ALPHA-1 PROTEASE INHIBITOR,ALPHA-1-ANTIPROTEINASE,SERPIN A1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SERPINA1, AAT, PI, PRO0684, PRO2209; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS APHA1 ANTITRYPSIN (C232S), SERPIN, INHIBITOR, COMPLEX, UNKNOWN KEYWDS 2 FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR C.CHUNG REVDAT 3 01-MAY-24 7NPL 1 REMARK REVDAT 2 14-APR-21 7NPL 1 JRNL REVDAT 1 07-APR-21 7NPL 0 JRNL AUTH J.LIDDLE,A.C.PEARCE,C.ARICO-MUENDEL,S.BELYANSKAYA, JRNL AUTH 2 A.BREWSTER,M.BROWN,C.W.CHUNG,A.DENIS,N.DODIC,A.DOSSANG, JRNL AUTH 3 P.EDDERSHAW,D.KLIMASZEWSKA,I.HAQ,D.S.HOLMES,A.JAGGER, JRNL AUTH 4 T.JAKHRIA,E.JIGOREL,K.LIND,J.MESSER,M.NEU,A.OLSZEWSKI, JRNL AUTH 5 R.RONZONI,J.ROWEDDER,M.RUDIGER,S.SKINNER,K.J.SMITH, JRNL AUTH 6 L.TROTTET,I.UINGS,Z.ZHU,J.A.IRVING,D.A.LOMAS JRNL TITL THE DEVELOPMENT OF HIGHLY POTENT AND SELECTIVE SMALL JRNL TITL 2 MOLECULE CORRECTORS OF Z ALPHA 1 -ANTITRYPSIN MISFOLDING. JRNL REF BIOORG.MED.CHEM.LETT. V. 41 27973 2021 JRNL REFN ESSN 1464-3405 JRNL PMID 33753261 JRNL DOI 10.1016/J.BMCL.2021.127973 REMARK 2 REMARK 2 RESOLUTION. 1.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 77.0 REMARK 3 NUMBER OF REFLECTIONS : 26990 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1357 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.82 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.86 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 24.81 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2657 REMARK 3 BIN FREE R VALUE : 0.3199 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 32 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2847 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 79 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.29460 REMARK 3 B22 (A**2) : -7.10450 REMARK 3 B33 (A**2) : 0.80980 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -7.02520 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.250 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.164 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.140 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.169 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.143 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2939 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3970 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1035 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 490 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2939 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 382 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2223 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.29 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.48 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -26.8758 -0.7872 21.0478 REMARK 3 T TENSOR REMARK 3 T11: -0.0095 T22: -0.0178 REMARK 3 T33: -0.0633 T12: -0.0892 REMARK 3 T13: -0.0331 T23: -0.0014 REMARK 3 L TENSOR REMARK 3 L11: 3.6904 L22: 0.7333 REMARK 3 L33: 1.5715 L12: 0.8592 REMARK 3 L13: -1.6723 L23: -0.5981 REMARK 3 S TENSOR REMARK 3 S11: -0.1545 S12: -0.1519 S13: 0.0876 REMARK 3 S21: -0.1519 S22: 0.2337 S23: -0.1867 REMARK 3 S31: 0.0876 S32: -0.1867 S33: -0.0792 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7NPL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1292114413. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97626 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26992 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.820 REMARK 200 RESOLUTION RANGE LOW (A) : 55.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 77.2 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.03300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 24.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.71400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: IN HOUSE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG1500 0.1M MES PH6.0, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.06000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.60000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.06000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.60000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -9 REMARK 465 ARG A -8 REMARK 465 GLY A -7 REMARK 465 SER A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 THR A 1 REMARK 465 ASP A 2 REMARK 465 PRO A 3 REMARK 465 GLN A 4 REMARK 465 GLY A 5 REMARK 465 ASP A 6 REMARK 465 ALA A 7 REMARK 465 ALA A 8 REMARK 465 GLN A 9 REMARK 465 LYS A 10 REMARK 465 THR A 11 REMARK 465 ASP A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 ASP A 17 REMARK 465 GLN A 18 REMARK 465 ASP A 19 REMARK 465 HIS A 20 REMARK 465 PRO A 21 REMARK 465 THR A 22 REMARK 465 PHE A 23 REMARK 465 LYS A 343 REMARK 465 GLY A 344 REMARK 465 THR A 345 REMARK 465 GLU A 346 REMARK 465 ALA A 347 REMARK 465 ALA A 348 REMARK 465 GLY A 349 REMARK 465 ALA A 350 REMARK 465 MET A 351 REMARK 465 PHE A 352 REMARK 465 LEU A 353 REMARK 465 GLU A 354 REMARK 465 ALA A 355 REMARK 465 ILE A 356 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 70 -136.07 50.79 REMARK 500 ASN A 81 34.53 71.80 REMARK 500 GLU A 199 92.46 -69.00 REMARK 500 ASP A 341 -73.52 -76.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue UKZ A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7NPK RELATED DB: PDB REMARK 900 7NPK CONTAINS SAME PROTEIN COMPLEXED WITH DIFFERENT LIGAND DBREF 7NPL A 2 394 UNP P01009 A1AT_HUMAN 26 418 SEQADV 7NPL MET A -9 UNP P01009 INITIATING METHIONINE SEQADV 7NPL ARG A -8 UNP P01009 EXPRESSION TAG SEQADV 7NPL GLY A -7 UNP P01009 EXPRESSION TAG SEQADV 7NPL SER A -6 UNP P01009 EXPRESSION TAG SEQADV 7NPL HIS A -5 UNP P01009 EXPRESSION TAG SEQADV 7NPL HIS A -4 UNP P01009 EXPRESSION TAG SEQADV 7NPL HIS A -3 UNP P01009 EXPRESSION TAG SEQADV 7NPL HIS A -2 UNP P01009 EXPRESSION TAG SEQADV 7NPL HIS A -1 UNP P01009 EXPRESSION TAG SEQADV 7NPL HIS A 0 UNP P01009 EXPRESSION TAG SEQADV 7NPL THR A 1 UNP P01009 EXPRESSION TAG SEQADV 7NPL SER A 232 UNP P01009 CYS 256 CONFLICT SEQRES 1 A 404 MET ARG GLY SER HIS HIS HIS HIS HIS HIS THR ASP PRO SEQRES 2 A 404 GLN GLY ASP ALA ALA GLN LYS THR ASP THR SER HIS HIS SEQRES 3 A 404 ASP GLN ASP HIS PRO THR PHE ASN LYS ILE THR PRO ASN SEQRES 4 A 404 LEU ALA GLU PHE ALA PHE SER LEU TYR ARG GLN LEU ALA SEQRES 5 A 404 HIS GLN SER ASN SER THR ASN ILE PHE PHE SER PRO VAL SEQRES 6 A 404 SER ILE ALA THR ALA PHE ALA MET LEU SER LEU GLY THR SEQRES 7 A 404 LYS ALA ASP THR HIS ASP GLU ILE LEU GLU GLY LEU ASN SEQRES 8 A 404 PHE ASN LEU THR GLU ILE PRO GLU ALA GLN ILE HIS GLU SEQRES 9 A 404 GLY PHE GLN GLU LEU LEU ARG THR LEU ASN GLN PRO ASP SEQRES 10 A 404 SER GLN LEU GLN LEU THR THR GLY ASN GLY LEU PHE LEU SEQRES 11 A 404 SER GLU GLY LEU LYS LEU VAL ASP LYS PHE LEU GLU ASP SEQRES 12 A 404 VAL LYS LYS LEU TYR HIS SER GLU ALA PHE THR VAL ASN SEQRES 13 A 404 PHE GLY ASP THR GLU GLU ALA LYS LYS GLN ILE ASN ASP SEQRES 14 A 404 TYR VAL GLU LYS GLY THR GLN GLY LYS ILE VAL ASP LEU SEQRES 15 A 404 VAL LYS GLU LEU ASP ARG ASP THR VAL PHE ALA LEU VAL SEQRES 16 A 404 ASN TYR ILE PHE PHE LYS GLY LYS TRP GLU ARG PRO PHE SEQRES 17 A 404 GLU VAL LYS ASP THR GLU GLU GLU ASP PHE HIS VAL ASP SEQRES 18 A 404 GLN VAL THR THR VAL LYS VAL PRO MET MET LYS ARG LEU SEQRES 19 A 404 GLY MET PHE ASN ILE GLN HIS SER LYS LYS LEU SER SER SEQRES 20 A 404 TRP VAL LEU LEU MET LYS TYR LEU GLY ASN ALA THR ALA SEQRES 21 A 404 ILE PHE PHE LEU PRO ASP GLU GLY LYS LEU GLN HIS LEU SEQRES 22 A 404 GLU ASN GLU LEU THR HIS ASP ILE ILE THR LYS PHE LEU SEQRES 23 A 404 GLU ASN GLU ASP ARG ARG SER ALA SER LEU HIS LEU PRO SEQRES 24 A 404 LYS LEU SER ILE THR GLY THR TYR ASP LEU LYS SER VAL SEQRES 25 A 404 LEU GLY GLN LEU GLY ILE THR LYS VAL PHE SER ASN GLY SEQRES 26 A 404 ALA ASP LEU SER GLY VAL THR GLU GLU ALA PRO LEU LYS SEQRES 27 A 404 LEU SER LYS ALA VAL HIS LYS ALA VAL LEU THR ILE ASP SEQRES 28 A 404 GLU LYS GLY THR GLU ALA ALA GLY ALA MET PHE LEU GLU SEQRES 29 A 404 ALA ILE PRO MET SER ILE PRO PRO GLU VAL LYS PHE ASN SEQRES 30 A 404 LYS PRO PHE VAL PHE LEU MET ILE GLU GLN ASN THR LYS SEQRES 31 A 404 SER PRO LEU PHE MET GLY LYS VAL VAL ASN PRO THR GLN SEQRES 32 A 404 LYS HET UKZ A 401 27 HET GOL A 402 6 HETNAM UKZ N-((1S,2R)-1-(3-CHLORO-2-METHYLPHENYL)-1-HYDROXYPENTAN- HETNAM 2 UKZ 2-YL)-2-OXOINDOLINE-4-CARBOXAMIDE HETNAM GOL GLYCEROL HETSYN UKZ ~{N}-[(1~{S},2~{R})-1-(3-CHLORANYL-2-METHYL-PHENYL)-1- HETSYN 2 UKZ OXIDANYL-PENTAN-2-YL]-2-OXIDANYLIDENE-1,3- HETSYN 3 UKZ DIHYDROINDOLE-4-CARBOXAMIDE; N-[(1S,2R)-1-(3- HETSYN 4 UKZ CHLORANYL-2-METHYL-PHENYL)-1-OXIDANYL-PENTAN-2-YL]-2- HETSYN 5 UKZ OXIDANYLIDENE-1,3-DIHYDROINDOLE-4-CARBOXAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 UKZ C21 H23 CL N2 O3 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *79(H2 O) HELIX 1 AA1 ILE A 26 SER A 45 1 20 HELIX 2 AA2 SER A 53 LEU A 66 1 14 HELIX 3 AA3 LYS A 69 LEU A 80 1 12 HELIX 4 AA4 PRO A 88 ASN A 104 1 17 HELIX 5 AA5 GLN A 105 LEU A 110 1 6 HELIX 6 AA6 VAL A 127 HIS A 139 1 13 HELIX 7 AA7 ASP A 149 THR A 165 1 17 HELIX 8 AA8 LYS A 259 LEU A 267 1 9 HELIX 9 AA9 THR A 268 ASN A 278 1 11 HELIX 10 AB1 LEU A 299 LEU A 306 1 8 HELIX 11 AB2 THR A 309 SER A 313 5 5 SHEET 1 AA1 7 ILE A 50 PHE A 52 0 SHEET 2 AA1 7 PRO A 382 VAL A 388 -1 O MET A 385 N PHE A 52 SHEET 3 AA1 7 PHE A 370 GLU A 376 -1 N MET A 374 O PHE A 384 SHEET 4 AA1 7 ALA A 248 PRO A 255 -1 N THR A 249 O ILE A 375 SHEET 5 AA1 7 SER A 237 TYR A 244 -1 N LEU A 240 O PHE A 252 SHEET 6 AA1 7 THR A 214 SER A 232 -1 N GLN A 230 O VAL A 239 SHEET 7 AA1 7 GLU A 204 ASP A 211 -1 N GLU A 204 O MET A 220 SHEET 1 AA2 8 ILE A 50 PHE A 52 0 SHEET 2 AA2 8 PRO A 382 VAL A 388 -1 O MET A 385 N PHE A 52 SHEET 3 AA2 8 PHE A 370 GLU A 376 -1 N MET A 374 O PHE A 384 SHEET 4 AA2 8 ALA A 248 PRO A 255 -1 N THR A 249 O ILE A 375 SHEET 5 AA2 8 SER A 237 TYR A 244 -1 N LEU A 240 O PHE A 252 SHEET 6 AA2 8 THR A 214 SER A 232 -1 N GLN A 230 O VAL A 239 SHEET 7 AA2 8 ARG A 282 PRO A 289 -1 O LEU A 286 N ARG A 223 SHEET 8 AA2 8 GLU A 363 LYS A 365 1 O VAL A 364 N SER A 285 SHEET 1 AA3 5 GLU A 141 VAL A 145 0 SHEET 2 AA3 5 LEU A 112 SER A 121 1 N LEU A 118 O PHE A 143 SHEET 3 AA3 5 PHE A 182 GLY A 192 -1 O ALA A 183 N PHE A 119 SHEET 4 AA3 5 LYS A 331 ILE A 340 1 O THR A 339 N GLY A 192 SHEET 5 AA3 5 ILE A 293 ASP A 298 -1 N ILE A 293 O LEU A 338 SITE 1 AC1 11 LYS A 193 TRP A 194 MET A 221 TYR A 244 SITE 2 AC1 11 LEU A 288 PRO A 289 LYS A 290 LEU A 291 SITE 3 AC1 11 GLU A 342 PHE A 372 MET A 374 SITE 1 AC2 8 ARG A 196 PHE A 227 MET A 242 LYS A 243 SITE 2 AC2 8 ARG A 281 HOH A 522 HOH A 527 HOH A 550 CRYST1 114.120 39.200 90.450 90.00 105.38 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008763 0.000000 0.002410 0.00000 SCALE2 0.000000 0.025510 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011466 0.00000